IQVIA

IQVIA (Nasdaq/NYSE: IQV) is a Life Sciences Tools & Services company operating within the Health Care sector of the US equity market.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

The company reports trailing twelve-month revenue of $9.74B and net income of $274.00M.

Key metrics include a return on equity of 4.4%, a debt-to-equity ratio of 3.75.

Use FINOTAUR to track IQV's price action, review fundamentals, and stay current with company news — all in one research dashboard.